IMNN
Imunon, Inc. Common Stock
stockNASDAQ
At CloseOct 2, 2026 3:59:57 PM EDT
1.29USD-2.273%(-0.03)94,817
Pre-marketOct 2, 2026 8:32:30 AM EDT
1.37USD+3.788%(+0.05)
Loading…
Loading…
7.24M
Healthcare
Biotechnology
HQ
Lawrenceville, NJ, USA
Previous Close
$1.32
Beta
0.60
52-Week High
$5.55 2025-10-03
52-Week Low
$1.26 2026-10-02
SMA 50
$1.52
SMA 200
$2.50
Avg. Vol 10D
157,035
Avg. Vol 30D
124,482
Avg. Vol 90D
128,773
Relative Vol
0.76
5.61M
3.57M
63.64%
193,639
5.42%
1.26
42%/58%
44.95%
23.94%
6.4200%
150,000
332
1,029
2,937
Nov 12, 2026 (38d)
Aug 7, 2025 · 1-for-1
Oct 1, 2026
IMNN: R&D Day Highlights IMNN-001 Data in Frontline Ovarian Cancer · 
Zacks Small Cap Research
Sep 24, 2026
Sep 23, 2026
Imunon, Inc. (IMNN) Shareholder/Analyst Call Transcript · 
Seeking Alpha
Sep 22, 2026
IMNN Profile
celsion is a biopharmaceutical company dedicated to the research and development of innovative, targeted therapies that address unmet medical needs in oncology. with the recent acquisition of egen, inc., celsion has become a fully integrated company with an extensive, complementary, multi-phase clinical pipeline; platform technologies for the discovery of novel, nucleic acid-based immunotherapies and other anti-cancer dna/rna therapies; and expertise from bench to bedside.
IMNN Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 1.38 | 2026-09-28 | -6.52% | 0.745 |
| 1M | 1.58 | 2026-09-04 | -18.35% | 2.442 |
| 3M | 1.98 | 2026-07-06 | -34.85% | 1.103 |
| 6M | 3.14 | 2026-04-06 | -58.92% | 0.753 |
| 1Y | 5.37 | 2025-10-03 | -75.98% | 0.604 |
| 2Y | 14.09 | 2024-10-04 | -90.84% | — |
| 5Y | 23.87 | 2022-09-21 | -94.60% | 0.613 |
IMNN Stock Summary
Imunon, Inc. Common Stock (NASDAQ:IMNN) stock price today is $1.29, and today's volume is 94,817. IMNN is down 2.273% today. The 30 day average volume is 124,482. IMNN market cap is $7.24M with 5.61M shares outstanding.